Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – New research suggests that older patients with advanced renal cell carcinoma glean as much benefit from sorafenib as do their younger counterparts. Moreover,…
NEW YORK (Reuters Health) – The use of cardioselective beta-blockers can improve survival in “carefully selected” COPD patients undergoing vascular surgery, according to a report in the first…
NEW YORK (Reuters Health) – Detection of JC virus, an important cause of progressive multifocal leukoencephalopathy (PML) in immunosuppressed patients, is not a good predictor of PML risk…
NEW YORK (Reuters Health) – While raloxifene and tamoxifen are broadly similar in reducing breast cancer risk, raloxifene appears also to lower the odds of developing endometrial cancer,…
NEW YORK (Reuters Health) – Alteplase can improve stroke outcomes even when it is not given until 3 to 4.5 hours after the stroke began, according to a…
NEW YORK (Reuters Health) – In the treatment of lower urinary tract symptoms in men, extended-release oxybutynin plus tamsulosin is more effective than tamsulosin alone and just as…
NEW YORK (Reuters Health) – In patients with diabetes and coronary heart disease, an impaired antiplatelet response to low-dose aspirin can be overcome by increasing the aspirin dose…
NEW YORK (Reuters Health) – Chronic kidney disease (CKD) puts hospitalized patients at increased risk for adverse events related to potential lapses in patient safety, according to data…
NEW YORK (Reuters Health) – In a postmortem study of patients with Alzheimer’s disease, diabetic subjects treated with both insulin and oral hypoglycemic agents had lower neuritic plaque…
NEW YORK (Reuters Health) – The results of a new study suggest that patients receiving long-term warfarin therapy do not need to stop the drug prior to coronary…
